Safety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis

NCT01848041 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Blepharoptosis

Interventions

DRUG: RVL-1201
DRUG: RVL-1201 Vehicle Placebo

Sponsor

RVL Pharmaceuticals, Inc.